Emerging treatment mechanisms for depression: focus on glutamate and synaptic plasticity

被引：224
作者：
Gerhard, Danielle M. [1 ]
Wohleb, Eric S. [2 ]
Duman, Ronald S. [2 ]
机构：
[1] Yale Univ, Dept Psychol, New Haven, CT 06511 USA
[2] Yale Univ, Mol Psychiat, New Haven, CT 06711 USA
来源：
DRUG DISCOVERY TODAY | 2016年 / 21卷 / 03期
关键词：
METHYL-D-ASPARTATE; MEDIAL PREFRONTAL CORTEX; NMDA RECEPTOR BLOCKADE; PROOF-OF-CONCEPT; ANTIDEPRESSANT EFFICACY; PROTEIN EXPRESSION; MAJOR DEPRESSION; PARTIAL AGONIST; D-CYCLOSERINE; KETAMINE;
D O I：
10.1016/j.drudis.2016.01.016
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Major depression is a chronic and debilitating illness that effects approximately 1 in 5 people, but currently available treatments are limited by low rates of efficacy, therapeutic time lag, and undesirable side effects. Recent efforts have been directed towards investigating rapid-acting agents that reverse the behavioral and neuronal deficits of chronic stress and depression, notably the glutamate NMDA receptor antagonist ketamine. The cellular mechanisms underlying the rapid antidepressant actions of ketamine and related agents are discussed, as well as novel, selective glutamatergic receptor targets that are safer and have fewer side effects.
引用
收藏
页码：454 / 464
页数：11
相关论文
共 100 条
  • [1] Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression
    aan het Rot, Marije
    Collins, Katherine A.
    Murrough, James W.
    Perez, Andrew M.
    Reich, David L.
    Charney, Dennis S.
    Mathew, Sanjay J.
    [J]. BIOLOGICAL PSYCHIATRY, 2010, 67 (02) : 139 - 145
  • [2] BLOCKADE OF DIFFERENT MUSCARINIC RECEPTOR SUBTYPES CHANGES THE EQUILIBRIUM BETWEEN EXCITATION AND INHIBITION IN RAT VISUAL CORTEX
    Amar, M.
    Lucas-Meunier, E.
    Baux, G.
    Fossier, P.
    [J]. NEUROSCIENCE, 2010, 169 (04) : 1610 - 1620
  • [3] Activity and connectivity of brain mood regulating circuit in depression: A functional magnetic resonance study
    Anand, A
    Li, Y
    Wang, Y
    Wu, JW
    Gao, SJ
    Bukhari, L
    Mathews, VP
    Kalnin, A
    Lowe, MJ
    [J]. BIOLOGICAL PSYCHIATRY, 2005, 57 (10) : 1079 - 1088
  • [4] L-655,708 enhances cognition in rats but is not proconvulsant at a dose selective for α5-containing GABAA receptors
    Atack, John R.
    Bayley, Peter J.
    Seabrook, Guy R.
    Wafford, Keith A.
    McKernan, Ruth M.
    Dawson, Gerard R.
    [J]. NEUROPHARMACOLOGY, 2006, 51 (06) : 1023 - 1029
  • [5] In vivo labelling of α5 subunit-containing GABAA receptors using the selective radioligand [3H]L-655,708
    Atack, JR
    Alder, L
    Cook, SM
    Smith, AJ
    McKernan, RM
    [J]. NEUROPHARMACOLOGY, 2005, 49 (02) : 220 - 229
  • [6] NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
    Autry, Anita E.
    Adachi, Megunai
    Nosyreva, Elena
    Na, Elisa S.
    Los, Maarten F.
    Cheng, Peng-fei
    Kavalali, Ege T.
    Monteggia, Lisa M.
    [J]. NATURE, 2011, 475 (7354) : 91 - U109
  • [7] BDNF Val66Met Impairs Fluoxetine-Induced Enhancement of Adult Hippocampus Plasticity
    Bath, Kevin G.
    Jing, Deqiang Q.
    Dincheva, Iva
    Neeb, Christine C.
    Pattwell, Siobhan S.
    Chao, Moses V.
    Lee, Francis S.
    Ninan, Ipe
    [J]. NEUROPSYCHOPHARMACOLOGY, 2012, 37 (05) : 1297 - 1304
  • [8] Antidepressant effects of ketamine in depressed patients
    Berman, RM
    Cappiello, A
    Anand, A
    Oren, DA
    Heninger, GR
    Charney, DS
    Krystal, JH
    [J]. BIOLOGICAL PSYCHIATRY, 2000, 47 (04) : 351 - 354
  • [9] Birmes P, 2003, CAN MED ASSOC J, V168, P1439
  • [10] BDNF val66 met allele is associated with reduced hippocampal volume in healthy subjects
    Bueller, JA
    Aftab, M
    Sen, S
    Gomez-Hassan, D
    Burmeister, M
    Zubieta, JK
    [J]. BIOLOGICAL PSYCHIATRY, 2006, 59 (09) : 812 - 815
12345678910